171 related articles for article (PubMed ID: 3475982)
1. An evaluation of squamous cell carcinoma antigen in patients with cervical squamous cell carcinoma.
Senekjian EK; Young JM; Weiser PA; Spencer CE; Magic SE; Herbst AL
Am J Obstet Gynecol; 1987 Aug; 157(2):433-9. PubMed ID: 3475982
[TBL] [Abstract][Full Text] [Related]
2. Serum squamous cell carcinoma antigen in gynecologic malignancies with special reference to cervical cancer.
Hsieh CY; Chang DY; Huang SC; Yen ML; Juang GT; Ouyang PC
Taiwan Yi Xue Hui Za Zhi; 1989 Aug; 88(8):797-800. PubMed ID: 2592943
[TBL] [Abstract][Full Text] [Related]
3. [Determination of the SCC antigen in the serum of patients with cervical cancer].
Crombach G; Würz H; Bolte A
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
[TBL] [Abstract][Full Text] [Related]
4. Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial determinations and tissue localization.
Maruo T; Shibata K; Kimura A; Hoshina M; Mochizuki M
Cancer; 1985 Jul; 56(2):302-8. PubMed ID: 2408732
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, and squamous cell carcinoma antigen in the detection of cervical cancers.
Lam CP; Yuan CC; Jeng FS; Tsai LC; Yeh SH; Ng HT
Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jul; 50(1):7-13. PubMed ID: 1326391
[TBL] [Abstract][Full Text] [Related]
6. [The importance of the SCC antigen in the diagnosis and follow-up of cervix carcinoma. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)].
Crombach G; Würz H; Herrmann F; Kreienberg R; Möbus V; Schmidt-Rhode P; Sturm G; Caffier H; Kaesemann H
Dtsch Med Wochenschr; 1989 May; 114(18):700-5. PubMed ID: 2714197
[TBL] [Abstract][Full Text] [Related]
7. Squamous cell carcinoma antigen in patients with cancer of the uterine cervix.
Fuith LC; Daxenbichler G
Gynecol Obstet Invest; 1988; 26(1):77-82. PubMed ID: 3169633
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of squamous cell carcinoma antigen and ovarian carcinoma antigen (CA 125) in patients with benign and malignant diseases of the uterine cervix.
Gocze PM; Vahrson HW; Freeman DA
Oncology; 1994; 51(5):430-4. PubMed ID: 8052484
[TBL] [Abstract][Full Text] [Related]
9. Comparison between squamous cell carcinoma-associated antigen and CA-125 in patients with carcinoma of the cervix.
Lehtovirta P; Viinikka L; Ylikorkala O
Gynecol Oncol; 1990 May; 37(2):276-8. PubMed ID: 2344974
[TBL] [Abstract][Full Text] [Related]
10. Transformation of histological tumor type of the cervix expressed in different tumor markers in the serum.
Aalders JG; de Bruijn HW; Oosterhuis JW; Duk JM
Gynecol Oncol; 1990 Jan; 36(1):110-2. PubMed ID: 2295441
[No Abstract] [Full Text] [Related]
11. Tumor antigen of human cervical squamous cell carcinoma: correlation of circulating levels with disease progress.
Kato H; Miyauchi F; Morioka H; Fujino T; Torigoe T
Cancer; 1979 Feb; 43(2):585-90. PubMed ID: 421183
[TBL] [Abstract][Full Text] [Related]
12. Squamous-cell carcinoma antigen (SCC-A) values related to clinical outcome of pre-invasive and invasive cervical carcinoma.
Brioschi PA; Bischof P; Delafosse C; Krauer F
Int J Cancer; 1991 Feb; 47(3):376-9. PubMed ID: 1704354
[TBL] [Abstract][Full Text] [Related]
13. Monitoring the course of cervical carcinoma with the squamous cell carcinoma serum radioimmunoassay.
Holloway RW; To A; Moradi M; Boots L; Watson N; Shingleton HM
Obstet Gynecol; 1989 Dec; 74(6):944-9. PubMed ID: 2586961
[TBL] [Abstract][Full Text] [Related]
14. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.
Duk JM; Aalders JG; Fleuren GJ; Krans M; De Bruijn HW
Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225
[TBL] [Abstract][Full Text] [Related]
15. Serum level of squamous cell carcinoma antigen and tumor size are useful to identify preoperatively patients at high risk of cervical cancer.
Chou CY; Wang ST; Kuo HC; Tzeng CC; Yao BL
Cancer; 1994 Nov; 74(9):2497-501. PubMed ID: 7923006
[TBL] [Abstract][Full Text] [Related]
16. Experiences with SCC antigen, a new tumor marker for cervical carcinoma.
Meier W; Eiermann W; Stieber P; Schneider A; Fateh-Moghadam A; Hepp H
Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1555-9. PubMed ID: 2591447
[TBL] [Abstract][Full Text] [Related]
17. Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinomas of the uterine cervix.
Crombach G; Scharl A; Vierbuchen M; Würz H; Bolte A
Cancer; 1989 Apr; 63(7):1337-42. PubMed ID: 2920361
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of SCC antigen in patients with advanced cervix cancer treated with radiation].
Roszak A; Bratos K; Górny A; Mackiewicz A
Ginekol Pol; 1996 Sep; 67(9):457-9. PubMed ID: 9289466
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of squamous cell carcinoma antigen in patients with a benign disease of the skin.
Duk JM; van Voorst Vader PC; ten Hoor KA; Hollema H; Doeglas HM; de Bruijn HW
Cancer; 1989 Oct; 64(8):1652-6. PubMed ID: 2790678
[TBL] [Abstract][Full Text] [Related]
20. SCC tumour marker and its relationship to clinical stage in squamous cervical cancer.
Henry RJ; Dodd JK; Tyler JP; Houghton CR
Aust N Z J Obstet Gynaecol; 1987 Nov; 27(4):338-40. PubMed ID: 3453675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
